calendar
4,293 catalysts · 3,153 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
next 91 dayslessmore
MonWedFri
4,293 catalysts · 3,153 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
Therapy area: Musculoskeletal Disorders. Indication: Bone Fracture
Therapy area: Dermatology. Indication: Wounds
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Central Nervous System. Indication: Pain
Therapy area: Hematological Disorders. Indication: Iron Deficiency Anemia
Therapy area: Hematological Disorders, Mouth and Dental Disorders. Indication: Dental Caries, Gingivitis, Hemorrhage, Periodontitis
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Myelodysplastic Syndrome (Preleukemia)
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Oncology. Indication: Chronic Myelomonocytic Leukemia (CMML)
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Central Nervous System, Mouth and Dental Disorders. Indication: Post-Operative Pain, Unspecified Mouth and Dental Disorders
Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)
Therapy area: Central Nervous System, Immunology. Indication: Delirium, Inflammation
Therapy area: Hormonal Disorders, Women's Health. Indication: Menstrual Disorders, Unspecified Hormonal Disorders
Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders
Items: 1.01, 7.01, 9.01
Items: 1.01, 9.01
Items: 3.01
Items: 5.02
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.01, 9.01
Items: 8.01, 9.01
Items: 5.02
Items: 5.02, 9.01
Items: 1.01, 8.01, 9.01
Items: 5.02
Items: 5.02
Items: 1.01, 2.01, 3.02, 9.01
Items: 9.01
Items: 5.07
Items: 1.01, 8.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.01, 9.01
Items: 5.03, 9.01
Items: 1.01, 9.01
Items: 5.02, 9.01
Items: 2.03
Items: 7.01, 8.01, 9.01
Items: 2.04
Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease
Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease
Therapy area: Ophthalmology. Indication: Age Related Macular Degeneration, Macular Degeneration, Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Infectious Disease. Indication: Unspecified Influenza Virus Infections
Therapy area: Oncology. Indication: Lung Adenocarcinoma, Metastatic Colorectal Cancer, Metastatic Ovarian Cancer, Solid Tumor, Squamous Cell Carcinoma, Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Triple-Negative Breast Cancer (TNBC), Uterine Cancer
Therapy area: Hematological Disorders, Immunology. Indication: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), Lupus Nephritis, Thrombocytopenia